RecruitingNot applicableNCT05644522
Rare condition
Postpoliomyelitis syndrome
3
studies recruiting now
as of 7 Sept 2026
29
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
17 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT07478172
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RecruitingNCT05663008
Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
Showing the 3 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Postpoliomyelitis syndrome studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Postpoliomyelitis syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Postpoliomyelitis syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
7 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3L-Citrulline
Phase 3Sodium Chloride (Aqsia (balanced salt soln))
Phase 3Modafinil (Modafinil)
Phase 3Levocarnitine (Carnitor)
Phase 3Piracetam (Gabacet)
Phase 3Human Immunoglobulin G (Flebogamma dif (previously flebogammadif))
Phase 2Poliovirus Vaccine Inactivated
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).